COMP <GO>
VATE vs TMO // OPERATING MARGIN
INNOVATE Corp. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: VATE 3
— TMO 6
▲ OPERATING MARGIN LEADER: TMO
LAST: $5.51 (-5.00%) • MKT CAP: $79.1M
operating-margins
2.30%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VATE VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VATE | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 16.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 9.30% | +75.70 | VATE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.40% | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | 2.30% | 17.40% | -15.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | -4.90% | 15.10% | -20.00 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | 3.90% | +8.60 | VATE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.78% | 0.24% | +2.54 | VATE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 4.50 | -4.30 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.6 | 62.9 | -24.30 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $79.1M | $262.22B | -$262.14B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VATE REV | TMO REV | VATE GROSS % | TMO GROSS % | VATE FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.25B | $44.56B | 16.0% | — | $146.6M | $6.29B |
| FY 2024 | $1.11B | $42.88B | 18.9% | — | -$9.9M | $7.27B |
| FY 2023 | $1.42B | $42.86B | — | — | $26.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VATE // BETA —
TMO // BETA 0.94